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ABSTRACT 
Tuberous sclerosis is a genetic disorder with incidence of 1 into 6000 birth. It is a multi-systemic disorder. 
Seizures associated with tuberous sclerosis (TS) can be difficult to control with medical therapy. 
Objective:  To determine the role of surgery for the management of seizures and other symptoms in Tuberous 
Sclerosis. 
Material and Method:  Four patients with TSC who underwent surgery were admitted in the Department of 
Neurosurgery Sheikh Zayed Hospital, Rahim Yar Khan and Department of Neurosurgery, PGMI / Lahore 
General Hospital, Lahore. 
Results:  We admitted 5 cases, 3 males and 2 females. All presenters with seizers other presenting feature were 
headache and vomiting in all 5 cases, vomiting in 5 cases. All cases were operated were craniotomy and removal 
of tumour. Surgery were V.P. Shunt was performed in 3 cases. All 5 cases revealed excellent outcome and 
seizures well controlled with anticonvulsant postoperatively which were poorly controlled preoperatively. All 5 
cases were discharged in satisfactory condition within 2 – 3 weeks. Histopathology the histopathology of all 5 
cases were subependymal giant cell astrocytoma (SEGA). 
Outcome:  All 5 cases revealed excellent outcome and the seizures were well controlled post-operatively with 
anticonvulsants. While pre-operative fits, were poorly controlled. All 5 cases were discharged in satisfactory 
condition with 2 – 3 weeks. 
Conclusion:  The surgery had excellent outcome for tuberous sclerosis provided timely decision is taken to treat 
the tumor and associated hydrocephalus. Most of these patients will lead ventriculoperitoneal shunt or EVD as an 
emergency step to save the life. 
Key Words:  Epilepsy, Tuberous Sclerosis. 
Abbreviations:  TCS: Tuberous Sclerosis, EVD: External Ventricular Drain, VP Shunt: Ventriculoperitoneal, 
SEGA: Sub-ependymal Giant Cell Astrocytoma. 
 
INTRODUCTION 
It is rare multi-systemic genetic disease that cause 
non-malignant tumor to grow in the brain and other 
vital organs such as the kidney, heart, eyes, lungs and 
skin. 
 The name, composed of the Latin tuber (Swell-
ing) and the Greek Sclerosis (hard). It refers to the 
pathological finding of thick, firm pale gyri called 
“tubers” in the brain of patient’s postmortem. The 
tubers were first described by Desire Magloire Bour-
neville in 1880; the cortical manifestation may some-
times still be known by the eponym Bourneville dise-
ase. 
 Unifocal onset seizures and mild to no develop-
ment delay at the time of surgery are predictive of ex-
cellent long term outcome. Tubers and sub ependymal 
nodules (SENs) are the typical brain lesions in TCS, 
and are present in 90 – 95% of the patients. 
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Fig. 1:  Pre-operative MRI showing Periventricular Tumour Extending into the Ventricle. 
 
 
 
Fig. 2: Post-operative CT Scan Brain showing Gross Total Removal of Tumor and VP Shunt in Situ. 
 
 Three types of brain tumors may be associated 
with TSC. 
1. Giant cell astrocytoma (grows and block the CSF 
flow). 
2. Cortical tubers. 
3. Sub-ependymal nodules; form in the wall of ven-
tricles. 
1. These nodules have a tendency to calcify as the 
patient ages. A nodule that marked by enhance-
ment and enlarges over time, leads to transformat-
ion into Sub-ependymal giant cell astrocytoma 
(SEGA). 
 A SEGA typically develops in the region of fora-
men of Monro leading to obstructive hydrocephalus. 
 In infants, the first clue is often the presence of 
seizures, delayed development or white patches on the 
skin. 
 
MATERIAL AND METHOD 
This is a retrospective and prospective study and 
conducted at Department of Neurosurgery, Sheikh 
Zayed Hospital, Rahim Yar Khan and PGMI / LGH, 
Lahore. Mode of admission was through OPD and
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Table 1:  The diagnosed criteria consists of major and minor diagnostic criteria. 
 
Major Features 
 Location Sign Onset Note 
  1. Head Facial angiofibromas or forehead plaque Infant – adult  
  2. Fingers and toes Non-traumatic ungula or perifungual fibroma Adolescent – adult  
  3. Skin Hypomelanotic macules Infant – child More than three 
  4. Skin Shagreen patch (connective tissue nevus) Child  
  5. Brain Cortical tuber Fetus  
  6. Brain Sub-ependymal nodule Child – adolescent  
  7. Brain Sub-ependymal giant cell astrocytoma Child – adolescent  
  8. Eyes Multiple retinal nodular hamartomas Infant  
  9. Heart Cardiac rhabdomyoma Fetus Single or multiple 
10. Lungs Lymphangioleiomyomatosis Adolescent – adult  
11. Kidneys Renal angiomyolipoma Child – adult 
10 and 11 together 
count as one major 
feature 
Minor Features 
 Location Sign Onset 
12. Teeth 
Multiple randomly distributed pits in dental 
enamel 
 
13. Rectum Hamartomatous rectal polyps Histological confirmation is suggested 
14. Bones Bone cysts  
15. Brain Cerebral white – matter “migration tracts” 
Radiographic confirmation is sufficient. 5 and 
15 together count as one major feature 
16. Gums Gingival fibromas  
17. 
Liver, spleen 
and other 
Non-renal haemartoma Histological confirmation suggested 
18. Eyes Retinal a chromic patch  
 
Emergency and we admitted we included 5 cases in 
our study, age varies from 9 to 22 years. Duration of 
study was 5 years from Jan. 2009 to Jan. 2013. Mean 
follow-up period of 2 years. The detail of 5 cases is 
below: 
 
1
st
 Case 
The first patient 22 years females came with H/O hea-
dache and seizure from last six months. She has gene-
ralized developmental delay which affects her school 
performance. She was getting phenytoin 100 mg TID 
table. MRI brain plain and with contrast was done 
which showed periventricular tumor and a small lateral 
ventricular hemorrhage. 
 On examination, there was no cutaneous manifest-
tation. 
 She was prepared for surgery. After a taking all 
the measures, surgery was done under G/A i.e. Right 
frontal craniotomy was done. 
 The approach was interhemispheric transcallosal 
and lateral ventricular tumor was removed. Biopsy 
confirmed to be sub-ependymal giant cell astrocytoma. 
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She continued to get phenytoin 100 mg TID. Later on, 
she developed hydrocephalus and finally VP shunt was 
done. She was discharged from ICU after a few days 
with satisfactory condition, confirming be the case of 
tuberous sclerosis, histopathologically. 
 
2
nd
 Case 
The Second case 12 years old boy known case of sei-
zure since 4
th
 day after birth, remained admitted in 
ICU for one month and he was getting antiepileptic 
drug for seizure disorder since birth. 
 He came with H/O Headache, vomiting and sei-
zure disorder again. CT scan brain done which shows 
intra-ventricular tumor with hydrocephalus, Sub-epen-
dymal nodules and cortical tubers. USG of abdomen 
shows Cystic lesions in the renal parenchyma. Patient 
was having aggressive behavior, agitation, Headache 
and vomiting. 
 Immediately, patient was advised for VP shunt and 
VP was done after the completion of all requirements. 
 After one week, patient was prepared for main sur-
gery and left frontal craniotomy was done and intra-
ventricular tumor resection was done through trans-
cortical approach. 
 Biopsy confirmed to be subependymal giant cell 
astrocytoma. 
 After two weeks stay in hospital patient was dis-
charged with anti-epileptic drugs in satisfactory condi-
tions. 
 
3
rd
 Case 
3
rd
 was 9 years male who was hyperactive, inattentive, 
impulsive and distractible. He speaks full sentence 
with reasonable articulation socially immature and has 
some obsessional feature. He came for seizure and 
headache at occipital region. Patient has also cutane-
ous stigma. 
 MRI of brain shows intra-ventricular tumor; sug-
gestive of tuberous sclerosis. 
 He was prepared for surgery and right frontal cra-
niotomy done with gross total resection of tumor done 
and EVD was inserted in ventricle for one week. Biop-
sy of tissue was sub-ependymal giant cell astrocytoma. 
 
4
th
 Case 
Fourth patient was two years female child came H/O 
seizure, intractable with conservative management. On 
examination, there were shagreen patches on her skin 
particularly back. 
 MRI of brain was advised. It showed sub-ependy-
mal growth in lateral ventricle and tubers scattered all 
over the brain. There was moderate Hydrocephalus. In 
emergency, EVD was done. In the next day patient 
was prepared for surgery and the Left frontal cranio-
tomy done and sub-ependymal growth was removed. 
Biopsy confirmed the sub-ependymal giant cell astro-
cytoma (SEGA). It was typically near the region of 
foramen of Monro. 
 Later on, in next week, VP shunt was done. After 
one week, she was discharged on anticonvulsant drugs 
with satisfactory remarks. 
 
5
th
 Case 
Fifth case was main, 30 with age, presenting with hea-
dache, vomiting and seizures. CT / MRI revealed left 
paraventricular tumour compressing the lateral ventri-
cular. He was operated by craniotomy left parietal re-
gion and grass total removal of tumour was performed. 
Patient has good recovery and was discharged within 
one week in satisfactory conditions. Histopathology 
report was subependymal giant cell astrocytoma (SE-
GA). 
 
Diagnostic Criteria 
Table 1 shows the detail of diagnostic criteria. The sel-
ection for cases for tuberous sclerosis was based on the 
following criteria. 
 
Inclusion Criteria 
1. Seizure of various kinds. The occurrence of 
infantile spasm has been contrasted with other ty-
pes of seizures. 
2. Delayed milestones with hyperactive, inattentive, 
impulsive and distractible attitude. 
3. Non-pigmented or hypo-pigmented areas of the 
skin of limb or trunk. 
4. Other manifestation such as lesion of the kidney 
viz renal angiomyolipoma. 
 
RESULTS 
Sex Incidence 
There were 3 male and 2 females as shown in table 2. 
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Table 2:  Sex Incidence. 
 
Sex Number Percentage 
Male 3   60% 
Female 2   40% 
Total 5 100% 
 
Age Range 
Age range was 9 to 32 years. 
 
Clinical Feature 
Table 3 shows the clinical feature. The age at which 
mental defect (1 Q? 70), poorly pigmented areas of 
skin along with lesion in kidney was noted. In one pat-
ient shagreen patches in lower half of trunk in back 
were noted. 
 
Table 3:  Clinical Presentation. 
 
Clinical Presentation Number Percentage 
Seizures 5 100% 
Headache 5 100% 
Vomiting 5 100% 
Aggressive Behaviour 3   60% 
Developmental Abnormalities 3   60% 
Poor Pigmentation of Skin 3   60% 
Shagreen Patches Skin 1   20% 
X-ray Intracranial 
Calcification 
2   40% 
Other Organs Involvement 
Like Kidney 
1   20% 
Tubers in Brain 4   80% 
 
 Seizures, headache and vomiting were presenting 
symptoms in all 5 (100%) cases, Aggressive behaviou-
ral in 3 (60%) cases, Developmental abnormalities in 3 
(60%), Poor pigmentation in 3 (60%) cases were other 
important symptoms, Shagreen patches on Skin in 1 
(20%) case. Plain x-ray skull revealed intracranial cal-
cification in 2 (40%) cases. 
 
Surgical Procedure 
Table 4 shows the detail of surgical procedure. Frontal
craniotomy and Trans-cortical approach for lateral 
ventricular tumor was adopted 3 (20%) cases and Fro-
ntal Inter-hemispheric, transcallosal approach was 
used 1 (20%) case. Temporoparietal Craniotomy was 
done 1 (20%) case. 
 
Table 4:  Surgical Procedure. 
 
Cases Procedure 1 Procedure 2 
Procedure 
3 
1 
Right Frontal 
Craniotomy and 
Interhemispheric 
Transcallosal 
Approach for 
Intraventricular 
Tumour 
V. P. Shunt  
2 V. P. Shunt 
Left Frontal 
Craniotomy, 
Trans-cortical 
Approach for 
Paraventricular 
Tumour 
 
3 
Right Frontal 
Craniotomy, 
Trans-cortical 
Approach for 
Intraventricular 
Tumour 
EVD for One 
Week 
 
4 EVD 
Left Frontal 
Craniotomy 
Trans-cortical 
Approach for 
Intraventricular 
Tumor 
V. P. 
Shunt 
5 
Left 
Temporoparietal 
Craniotomy and 
Trans-cortical 
Approach 
  
 
Table 5:  Histopathology. 
 
Histopathology 
No. of 
Cases 
Percentage 
Sub-opendymal Giant all 
Astrocytoma (SEGA) 
5 100 
 
Histopathology 
Table 5 shows the detail of histopathology. The histo-
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pathology of all 5 cases were subependymal giant cell 
astrocytoma (SEGA). 
 
OUTCOME 
All 5 cases revealed excellent outcome and the seizu-
res were well controlled post-operatively with anticon-
vulsants. While pre-operatively was, fits were poor 
controlled. All 5 cases were discharged in satisfactory 
condition with 2 – 3 weeks. 
 
DISCUSSION 
The tuberous sclerosis (TSC) complex, a multisystem, 
autosomal dominant disorder, affecting children and 
adults, results from mutation in one of two genes. It 
was first described by Bourneville in 1880, causes dis-
abling neurological disorders; epilepsy, mental retar-
dation and autism. In some patients, there may be 
hypo-pigmented skin patches, facial angiofibroma, 
renal angiomyolipomas and pulmonary lymphangio-
myomatosis. 
 In our 5 cases, 4 cases presented in emergency 
department with seizures, on further radiological find-
ing, one has renal cystic lesion. In MRI and CT, 4 
(80%) patients showed tuber in brain and 4 patients 
had sub-ependymal ventricular growth. In 1 patient 
there were skin pigmentation i.e. on the back and 
lower trunk, shagreen patches was observed. 
 In spite of wide variety of clinical presentation in 
TSC some form of seizure occurred in 100% of our 
patients, but in literature infantile spasm were an early 
type of seizure in 69% of children. 
 The TSC1 – TSC2 complex plays a central role in 
the integration of multiple cues to regulate cellular 
growth and differentiation. Mutations in TSC1 or TSC2 
result in widespread, devastating consequences. Key 
priorities for future research include elucidating the 
location of and functional relationship between TSC1 
and TSC2 and their pathways, determining whether 
Rheb is the sole downstream effect or of the TSC1 – 
TSC2 complex and whether mTOR is the only clini-
cally relevant target of Rheb, understanding the rela-
tionship between tubers and epilepsy, and investigat-
ing the role of estrogen in the pathogenesis of lym-
phangiomyomatosis. The recent delineation of the 
TSC biochemical signaling pathway suggests strate-
gies for developing targeted therapies including m-
TOR inhibition, which is being evaluated in clinical 
trials. 
CONCLUSIONS 
The surgery had excellent outcome for tuberous scle-
rosis provided timely decision is taken to treat the 
tumor and associated hydrocephalus most of these 
patients will lead ventriculoperitoneal shunt or EVD as 
an emergency step to save the life. 
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